CTLA4 and cancer: Cancer cells are able to evade anti-tumor response by overexpressing immunosuppressive molecules such as cytotoxic T-lymphocyte associated antigen 4 (CTLA-4), programmed cell death protein (PD-1), and its ligand PD-L1 [2].